[Elsevier/Sciencedirect] MA04.09 Patterns of Progression and Recurrence with Perioperative Durvalumab in Patients with Resectable NSCLC from AEGEAN 求助已关闭
|
发布
回复
积分
6840
30
MA04.08 Perioperative Tislelizumab for Resectable Non-small Cell Lung Cancer: Final Analysis of RATIONALE-315
20
Root-soil-microbe interactions mediate phosphorus and iron uptake from lithium iron phosphate nanomaterials
20
A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets
20
Non-suicidal self-injury: proposal to shift designation from disorder to a clinical specifier
50
PL03.10 Adjuvant Chemotherapy (CT) vs CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patients (NADIM ADJUVANT): a Randomized, Phase 3 Trial
